ExploreWatchlistsPricing
  1. JP-listed companies
  2. Linical Co., Ltd.
  3. Financials
  4. Operating expenses

Linical Co., Ltd. (2183)

Market cap
¥5.2B
P/E ratio
26.2x
Linical helps pharmaceutical companies develop and launch new drugs by providing clinical trial services, post-market safety monitoring, and drug discovery support.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndOperating expenses (Million JPY)YoY (%)
Mar 31, 20263,197+8.04%
Mar 31, 20252,959-3.06%
Mar 31, 20243,053+5.08%
Mar 31, 20232,905+15.02%
Mar 31, 20222,526+9.14%
Mar 31, 20212,314-8.36%
Mar 31, 20202,525-2.88%
Mar 31, 20192,600+54.17%
Mar 31, 20181,687+9.57%
Mar 31, 20171,539+6.77%
Mar 31, 20161,442+58.17%
Mar 31, 2015911

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat